Skip navigation
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Hepatology meetings & conferences

5 meetings & conferences listed in Hepatology 

Cholangiocarcinoma Foundation 2nd Annual Conference
United States

Cholangiocarcinoma Foundation 2nd Annual Conference

in cooperation with the Hepatobiliary Cancer Research Program at Huntsman Cancer Institute

February 5 & 6, 2015 Salt Lake City, Utah

This event will bring together subject matter experts in the field of cholangiocarcinoma including clinical physicians, researchers, palliative care nurses, pharmaceutical and government representatives, and patient advocates.

The 2015 Annual Conference will build upon the foundation laid at last year’s meeting as key opinion leaders and other professionals in the medical and scientific communities come together to collaborate and exchange knowledge. Throughout the program, attendees will be provided opportunities to promote dialogue, foster innovation, and share expertise with colleagues worldwide.

The program seeks to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma by:

• Presenting current data on translational and basic research activities

• Increasing the knowledge and understanding of attendees about key issues central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma

• Stimulating cross-cooperation and sharing best practices by developing, strengthening, and supporting collaborations through working groups

Who Should Attend?

• Researchers

• Clinical physicians

• Oncologists

• Radiologists

• Surgeons

• Gastroenterologists

• Hematologists

• Nurses specializing in oncology, intensive care, and palliative care

• Pharmaceutical Companies

• Government Regulators.

Gastroenterologist, Hematologist, Hepatologist, Nurse, Oncologist, Patient, Physician, Physician Researcher, Public Servant, Radiologist, Surgeon
Americas Hepato-Pancreato-Biliary Association 2015 Annual Meeting
United States

Americas Hepato-Pancreato-Biliary Association 2015 Annual Meeting

March 11-15, 2015 Miami Beach, Florida

Hepatologist, Physician, Physician Researcher, Surgeon
Liver Metabolism and Nonalcoholic Fatty Liver Disease (NAFLD)

Liver Metabolism and Nonalcoholic Fatty Liver Disease (NAFLD)

Joint with the meeting on Obesity and the Metabolic Syndrome: Mitochondria and Energy Expenditure

March 22—27, 2015 Whistler, British Columbia, Canada

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

Abnormalities in hepatic intermediary metabolism are common in obesity and are a significant source of morbidity and mortality in obese people. For example, nonalcoholic fatty liver disease (NAFLD) affects over 25% of the US population and has become the most common cause of liver failure and transplantation. NAFLD is also linked to the development of major metabolic diseases such as type 2 diabetes and cardiovascular diseases. Despite the central role of the liver in whole-body energy metabolism and its contribution to disease development, there are literally no dedicated meetings that focus on the cellular and mechanistic aspects of the regulation of liver metabolism. This meeting will bring together experts, both basic scientists and clinicians, across diverse fields including biochemistry, cell biology, genetics, hepatology, nutrition, physiology and virology to exclusively focus on the liver and bridge a translational divide. Meeting themes will center on regulation of hepatic energy metabolism, crosstalk between the liver and different organs and cell types and how alterations in macronutrient metabolism contribute to disease etiology. The objectives of this conference are to: 1) Expose scientists across diverse disciplines to different aspects of hepatic metabolism and NAFLD development; 2) Find synergies in research efforts to expedite our understand hepatic energy metabolism; and 3) Explore emerging metabolic targets for therapeutic interventions to prevent or alleviate NAFLD and related comorbidities.

Biochemist, Cell Biologist, Geneticist , Hepatologist, Molecular Biologist, Nutritionist, Physician Researcher, Physiologist, Virologist
15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)

15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)

June 26-28, 2015 Berlin, Germany

In June 2015 the 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) will be held in Berlin, Germany.

ISVHLD has a tradition of 43 years. Initially the focus was on discovery of hepatitis viruses, then it was the development of diagnostic procedures, vaccines, understanding pathophysiology and now therapies. In 2015 will be the time when many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. However public health will become very important to identify the patients in need for therapy and to make these new therapies accessible to all parts of the world. Furthermore we still need to develop better finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.

This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances made against the global health burden caused by all hepatitis viruses. For the first time the symposium will be organized in Germany taking place in its capital Berlin.

Hepatologist, Physician, Physician Researcher, Virologist
5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association

5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association

March 18-21, 2015 Singapore

The 5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) is one of region’s largest medical conferences dedicated to the study of liver, pancreas and biliary discipline. The event provides medical professionals an excellent platform for the exchange of clinical and scientific knowledge on the latest developments and emerging challenges of hepato-pancreato-biliary (HPB) disorders.

The four-day congress will feature an exciting line-up of expert speakers including top practitioners, opinion leaders and researchers. Delegates can look forward to an intensive knowledge-sharing event comprising plenary sessions, oral presentations and video screenings. There will be a host of networking opportunities for delegates to rub shoulders with top experts and opinion leaders.

Congress Secretariat for the 5th Biennial Congress of the Asian-Pacific Hepato-Pancreatro-Biliary Association
Tel: +65 6393 0202
Fax: +65 6292 7577

Hepatologist, Physician, Physician Researcher